Observation of Blood Lipid Outcomes in Lipid Clinic

Dyslipidemias Clinical Trial

Official title:

Observation of Blood Lipid Outcomes in Patients Who Receive Treatment in Lipid Clinic of Taipei MacKay Memorial Hospital

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04220164
• Other study ID #: 18MMHIS083e
• Status: Recruiting
• Start date: January 3, 2020
• Est. completion date: December 31, 2025

Study information

• Verified date: January 2020
• Source: Mackay Memorial Hospital
• Contact: Ting-Yun Lu
• Phone: 886-2-25433535
• Email: tingyunlu[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the physician will discuss with each individual patient and set an individualized LDL goal according to current guideline and regulation of National Health Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.

Description:

Hyperlipidemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD), and therefore it is beneficial to prevent the risk of ASCVD by controlling the prevalence of hyperlipidemia. According to CEPHEUS Pan-Asia survey, the rate of LDL goal attainment in hyperlipidemic patients of Taiwan was suboptimal, especially in high-risk patients. 2017 Taiwan lipid guideline for high-risk patients has been published and clearly defined the treatment goal of blood LDL-C for high-risk patients. Besides, Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the physician will discuss with each individual patient and set an individualized LDL goal according to current guideline and regulation of National Health Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: December 31, 2025
• Est. primary completion date: December 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• =20 years-old

• Abnormal lipid profiles according to 2017 Taiwan Lipid Guideline for High-risk Patients

Exclusion Criteria

• Reject to participate in this study

• Pregnant women

• Prisoner

• Illiteracy

• HIV patients

• Individuals who are mentally retarded, homeless, and handicapped

Related Conditions & MeSH terms

• Dyslipidemias

Intervention

Other:
• Education and inform the optimal threshold of LDL-C levels
Physicians educate patients and provide a clear information about optimal LDL-C value according to individual patient's condition according to current guidelines

Locations

Country	Name	City	State
Taiwan	Taiwan, Taipei, Mackay Memorial hospital	Taipei

Sponsors (2)

Lead Sponsor	Collaborator
Mackay Memorial Hospital	Amgen

Country where clinical trial is conducted

Taiwan, 

References & Publications (1)

Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, Wang CY, Chao TH, Liu PY, Su CH, Chien SC, Liou CW, Tang SC, Lee CC, Yu TY, Chen JW, Wu CC, Yeh HI; Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients. 2017 Taiwan lipid guidelines for high risk patients. J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24. Review. Erratum in: J Formos Med Assoc. 2018 Aug;117(8):749-750. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lipid profile	check serum level of LDL-C	12 month